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Summary
We describe the first examples of a series of cyclic pseudopeptide libraries that have been prepared in a system-
atic approach in order to facilitate both synthesis and subsequent deconvolution attempts. Our synthetic strategy
involved the attachment of a trifunctional amino acid (Asp, Asn or Glu) to a polystyrene resin via its side chain,
and stepwise chain elongation using either protected amino acids or a pseudodipeptide building block. Head to
tail cyclic peptides were formed by removal of the temporary N- and C-terminal protecting groups followed by
ring closure by amide formation. Cyclization of the hexa, hepta, and octapseudopeptides on the resin avoided
dimer formation, as monitored by mass spectrometry. We utilized a ‘psi-scan’ approach in which a second fixed
position was serially addressed by stepping a dipeptide surrogate, Proψ[CH2S]Gly around the rings to generate
a group of cyclic pseudopeptide sub-libraries. Oxidation ofψ[CH2S] toψ[CH2SO] helped validate the synthesis
and also provides a strategy for forming a new set of pseudopeptide libraries (previously described as ‘libraries
from libraries’). Our results suggest that libraries of cyclic pseudopeptides are an efficient method of preparing and
assaying these synthetically more challenging entities as potential drug leads.
Introduction
Peptides are an important class of molecules with po-
tential therapeutic utility in virtually all known human
disease categories. However, in spite of their wide-
spread use (insulin, vasopressins, calcitonin, LH-RH
analogs and Sandimmune among others) peptides are
often discounted as preferred new drug candidates due
to their lack of resistance toward enzymatic clearance
and poor transfer rates across cell membranes and in-
testinal mucosa. In order to transform a peptide lead
into a useful drug, several approaches including cy-
clization [1] and peptide backbone modifications [2,3]
can be employed. The resulting cyclic peptides and
Figure 1. Synthesis route of the preformed pseudodipeptides,
Boc-AAψ [CH2S]Gly-OH.
pseudopeptides therefore represent useful intermedi-
ates along the drug discovery pathway.
Intrigued by the potential of combinatorial libraries
[4,5], and especially peptide libraries [6], for the
identification of potential macromolecular ligands and
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Figure 2. (a) RP-HPLC profile of the pseudopeptide mixture H-Tyrψ [CH2S]Gly-Phe-Xxx-Leu-OH, where Xxx = (Ala, Glu, Lys,
Arg). Gradient: 15–65% buffer B in 28 min, monitored atλ = 214 nm. (b) RP-HPLC profile of the pseudopeptide mixture
H-Tyr-D-Alaψ [CH2NH]Gly-Xxx-Phe-Leu-OH, where Xxx = (Asp, Ser, Leu, Val). Note that the amount of benzyl-modified products in 2b
represents a considerably smaller proportion than in 2a suggesting the influence of theψ [CH2S] surrogate in enhancing the cationic alkylation
side products. Gradient: 15 to 35% buffer B in 48 min, monitoren atλ = 214 nm. Buffer A: 0.05% TFA/H2O. Buffer B: 0.05% TFA/AcCN.
drug leads, we reasoned that the combinatorial syn-
thesis of cyclic peptide and pseudopeptide libraries
would add a new dimension to the generation of mole-
cular diversity, thus providing a useful molecular tool
for facilitating drug lead discovery. In addition, due
to the availability of large numbers of cyclic peptides
and pseudopeptides (generated from the combinatorial
approach), some fundamental questions about these
novel ring systems can be perhaps more efficiently
addressed. These include the sequence dependence of
cyclizations for linear peptides and pseudopeptides, as
well as preferential interactions between various metal
ions and cyclic peptides and pseudopeptides (host-
guest relationships) using a combinatorial synthesis
approach.
To assist such studies, we have developed a general
strategy for synthesizing head-to-tail lactam cyclic
peptide libraries [7,8] using a resin bound cyclization
approach [9]. In subsequent reports, we have studied
the racemization problem of a C-terminal aspartic acid
residue during the synthesis [10] and explored library
variations in structure and ring size [11]. More re-
cently, we have reported our studies on metal binding
affinities of cyclic peptide mixtures [12] and on the
synthesis and characterization of cyclic pseudopep-
tides containing theψ[CH2NH] surrogate [13]. In this
report, we extend our study to cyclic pseudopeptide
libraries containing theψ[CH2S] andψ[CH2SO] sur-
rogates. These amide bond replacements were first
designed for incorporation within collagen sequences
[14] and for backbone modified linear LH-RH analogs
as potential contraceptive agents [15]. The facile ox-
idation of these compounds to sulfoxides, but not
sulfones, using hydrogen peroxide treatment was also
previously described [16]. The synthesis, characteri-
zation, and bioassays of these libraries are described.
Materials and Methods
Melting points were determined on a Thomas-Hoover
capillary melting point apparatus and are uncorrected.
Specific optical rotations were determined on a Jasco
Model 700 at the sodium D line. Proton NMR spec-
tra were recorded on a Bruker AMX-500 Fourier
Transform NMR spectrometer. TLC was performed
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Figure 3. Negative ESMS of L4 or cyclo(Proψ [CH2S]Gly-Yyy-Yyy-Yyy-Glu) where Yyy is a nearly equimolar mixture of lysine, leucine,
arginine, glutamic acid, serine, alanine and tyrosine. The theoretical distribution of this mixture consisted of 343 pseudohexapeptides with 84
unique masses ranging from 499 to 775.
on silica gel (Merck 254 plates) in the following
systems (v/v): (A) CHCl3/MeOH, 95:5; (B) ethyl
acetate/hexane, 1:1; and (C) CHCl3/MeOH/HOAc,
85:10:5; (D) acetone/hexane, 3:7. Solid phase reac-
tions were manually performed in 2 mL syringes using
a Teflon 42-vessel multiple peptide synthesis block
from CSPS (San Diego, CA). Reaction products were
visualized by UV fluorescence (254 nm) or 1% ninhy-
drin in ethanol. Amino acid analyses were performed
on a Dionex D-300 amino acid analyzer and a Dionex
CP-3 programmer at the Health Sciences Center of the
University of Louisville as follows: the pseudopeptide
mixtures were first hydrolyzed in 6 N HCl, contain-
ing 1 mg of phenol, at 110◦C for 20–24 h in sealed,
evacuated hydrolysis tubes, then derivatized using the
PICO TAG method developed by Waters-Millipore.
Molecular weight determinations were made using
electrospray mass spectrometry (ES–MS) at the Uni-
versity of Michigan on a Micromass (VG) Platform
quadrupole mass spectrometer (0–3000m/z) in posi-
tive and negative ionization modes. Peptides for mass
analysis were dissolved in 50% CH3CN:50% H2O.
Technical-grade dichloromethane and crude di-
methylformamide solvents were purchased from EM
Science, and were distilled prior to use. Protected
amino acids were purchased from Bachem Bio-
science Inc. (King of Prussia, PA) and Chem-Impex
International (IL). Benzotriazol-1-yl-oxy-tris(diethyl-
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amino)-phosphoniumhexafluorophosphate (BOP) was
purchased from Richelieu Biotechnologies. 1-Hydro-
xybenzotriazole (HOBt), N,N′-diisopropylethylamine
(DIEA), 9-fluorenylmethanol (HOFm), benzylchlo-
roformate (Z-Cl), and lithium aluminum hydride
(LiAlH 4) were products of Aldrich Chemical Co.
(Milwaukee).
Synthesis of Boc-Tyr(Bzl)-CH2OH (1)
BH3/THF (30 mL, 30 mmol) was transferred from a
sealed bottle to a round bottom flask maintained in
an acetone-dry ice bath. To the solution was added
3.71 g Boc-Tyr(Bzl)-OH (10 mmol) in THF dropwise
for 30 min. The reaction mixture was stirred at –40◦C
for 1 h, then at room temperature for 2 h. The reac-
tion was quenched by slowly adding ice cooled water
to the reaction mixture. The solution was evaporated
and extracted with EtOAc. The combined extracts
were washed with water, saturated NaHCO3, and sat-
urated NaCl solution. The EtOAc layer was dried with
anhydrous MgSO4, and evaporated to afford 2.96 g
product (82.8%) as a white solid: mp 100–103◦C;
[α]D: –0.424 (C1, EtOH); Rf (B) = 0.73; 1H NMR
(500 MHz, CDCl3) δ 1.39 (s, 9H, Boc CH3), 2.75 (d,
2H, β-CH2), 3.49 (m, 1H,α-H), 3.54 (m, 2H, CH2-
O), 3.63 (s, 1H, OH), 4.67 (s, 1H, CONH), 5.02 (s,
2H, CH2 of Bzl), 6.90 (d, 2H, 3,5-aromatic H of Tyr),
7.10 (d, 2H, 2,6-aromatic H of Tyr), 7.30–7.42 (m, 5H,
Ph of Bzl).
Synthesis of Boc-Pro-CH2OH (2)
The procedure used for this synthesis was virtually
identical to the preparation of Boc-Tyr(Bzl)-CH2OH:
85.9% yield; mp 57–59◦C; Rf (C) = 0.68;1H NMR
(500 MHz, CDCl3) δ 1.44 (s, 9H, Boc); 1.75 (m, 2H,
γ -CH2); 1.98 (m, 2H,β-CH2); 3.29–3.42 (mm, 2H,
δ-CH2); 3.55–3.62 (mm, 2H, CH2-O); 3.93 (d, 1H,
α-H); 4.73 (d,1H, -OH).
Synthesis of Boc-Tyr(Bzl)-CH2OTs (3)
To a solution of 2.9 g Boc-Tyr(Bzl)-CH2OH
(8.1 mmol) in 20 mL CHCl3 and 6.56 mL pyridine
(81 mmol) maintained at 0◦C was added 4.63 g tosyl
chloride (24.3 mmol) in CHCl3 over 15 min. Upon
the addition of tosyl chloride, the color of the solution
changed to yellow, and eventually to red. The reac-
tion mixture was stirred at room temperature for 1.5 h.
The solution was evaporated to dryness under reduced
pressure, the residue was extracted with a mixture of
Figure 4. Negative ESMS OF L4 (bottom spectrum) of
cyclo(Proψ [CH2S]Gly-Yyy-Yyy-Yyy-Glu and L35 (top spectrum)
or cyclo(Proψ [CH2SO]Gly-Yyy-Yyy-Yyy-Glu) where Yyy is a
nearly equimolar mixture of lysine, leucine, arginine, glutamic
acid, serine, alanine and tyrosine. Note the molecular weight shift
of 16 due to the additional oxygen atom in L35.
EtOAc and water. The combined organic extracts were
washed with cold water, 1 N HCl solution, water, 5%
NaHCO3 solution, water, and saturated NaCl solution.
The EtOAc layer was dried with anhydrous MgSO4,
and evaporated to afford 4.15 g crude product. Column
chromatography on silica gel (solvent gradients start-
ing from 100% hexane to 90% hexane/acetone, 80%
hexane/acetone, and 50% hexane/acetone) gave 3.10 g
(74.8%) purified product as a white solid. mp 155–
158◦C; Rf (A) = 0.41;1H NMR (500 MHz, CDCl3)
δ 1.37 (s, 9H, Boc CH3), 2.43 (s, 3H, CH3 of Tos),
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Figure 5a. Negative ESMS of L7 or cyclo(Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Asp) where Xxx is a nearly equimolar mixture of lysine, leucine,
arginine, glutamic acid, serine, and tyrosine. The theoretical distribution of this mixture consisted of 216 pseudohexapeptides with 56 unique
masses ranging from 533 to 761.
2.70 (dd, 1H,β-CH2), 2.78 (dd, 1H,β-CH2), 3.87 (m,
1H, α-H), 3.98 (d, 2H, CH2O), 4.69 (d, 1H, CONH),
5.00 (s, 2H, CH2 of Bzl), 6.82 (d, 2H, 3,5-aromatic H
of Tyr), 6.96 (d, 2H, 2,6-aromatic H of Tyr), 7.33 (m,
5H, Ph of Bzl). 7.39 (m, 2H, 3,5-aromatic H of Tos),
7.75 (d, 2H, 2,6-aromatic H of Tos).
Synthesis of Boc-Pro-CH2OTs (4)
The procedure is almost identical to the preparation
of Boc-Tyr(Bzl)-CH2OTs: white solid; yield 62.4%;
mp: 72–74◦C; Rf (C) = 0.77; 1H NMR (500 MHz,
CDCl3) δ 1.38 (d, 9H, Boc); 1.79 (m, 2H,γ -CH2);
1.90 (m, 2H,β-CH2); 2.42 (s, 3H, CH3 of Tos); 3.26
(m, 2H, δ-CH2); 3.86 (dd, 2H, CH2-OTs); 4.06 (m,
1H, α-H); 7.33 (m, 2H, 3,5-aromatic H of Tos); 7.76
(d, 2H, 2,6-aromatic H of Tos).
Synthesis of Boc-Tyr(Bzl)ψ[CH2S]Gly-OH (5)
Freshly shaved sodium metal (207 mg, 9 mmol) was
dissolved in 10 mL anhydrous ethanol solvent. To
this solution was added 0.313 mL freshly distilled
HSCH2COOH (4.5 mmol). Upon the addition of
HSCH2COOH, white solid immediately precipitated
out of solution. The suspension was stirred for 10 min,
then evaporated under reduced pressure. The residue
was dissolved in benzene and evaporated. This process
was repeated several times until a white solid was ob-
tained. The white solid was further dried and dissolved
in 2–3 mL DMSO under nitrogen. To the solution was
added 2.04 g Boc-Tyr(Bzl)-CH2OTs (4 mmol). The
reaction mixture was stirred at RT under nitrogen for
4 h, and then 15 mL cold water was added to the
reaction mixture. The aqueous solution was washed
with ether once, and brought to pH 3 by addition of
1 N HCl. The aqueous solution was extracted with
EtOAc (3×50 mL). The combined organic extracts
were washed with 1 N HCl solution, water, and satu-
rated NaCl solution. The EtOAc layer was dried with
MgSO4, and evaporated to afford 1.43 g pure product
(82.5%) as a white solid: mp 54–56◦C; Rf (D) = 0.28;
1H NMR (500 MHz, CDCl3) δ 1.39 (s, 9H, Boc CH3),
2.71 (m, 2H,β-CH2), 2.79 (m, 2H, CH2-S), 3.27 (m,
2H, S-CH2), 4.00 (br s, 1H,α-H), 4.70 (br s, 1H,
CONH), 5.01 (s, 2H, CH2 of Bzl), 6.88 (d, 2H, 3,5-
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Figure 5b. Positive mode ESMS of L7 or cyclo(Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Asp) where Xxx is a nearly equimolar mixture of lysine,
leucine, arginine, glutamic acid, serine, and tyrosine. Note that the positive mode MS is complementary to the negative mode in that it
corresponds to most of the expected base-containing (Lys and Arg) peptide components.
aromatic H of Tyr), 7.07 (d, 2H, 2,6-aromatic H of
Tyr), 7.28–7.41 (m, 5H, Ph of Bzl). ES-MS [M-H]− =
430.4, found: 430.5.
Synthesis of Boc-Proψ[CH2S]Gly-OH (6)
A procedure was used similar to the preparation
of Boc-Tyr(Bzl)ψ[CH2S]Gly-OH for synthesizing
this title compound. Specifically, 2.5 g Boc-Pro-
CH2OTs (4) (7.1 mmol) was caused to react with the
freshly prepared disodium salt of mercaptoacetic acid
(7.5 mmol) in 10 mL of DMSO at room temperature
for 6 h. Following workup as above, a white solid was
obtained: 70% yield; mp: 70–72◦C; Rf (C) = 0.57.1H
NMR (500 MHz, CDCl3) δ 1.44 (s, 9H, Boc); 1.82
(m, 3H,γ -CH2 andβ-H); 1.97 (m, 1H,β-H); 2.59 (br
s, 1H, CH2-S-); 2.94 (dd, 1H, CH2-S); 3.27 (m, 2H,δ-
CH2); 3.34 (m, 2H, S-CH2); 3.89–3.98 (m, 1H,α-H).
ES-MS [M-H]− = 274, found: 273.9.
Synthesis of H-Tyrψ[CH2S]Gly-Phe-Xxx-Leu-OH
(7), where: Xxx = Ala, Lys, Glu, and Arg
The synthesis of the title pseudopeptide mixture
was initiated with 200 mg of Boc-Leu-Merrifield
resin which was prepared following treatment of
chloromethylated polystyrene resin (Kodak) with the
cesium salt of Boc-leucine (1 equiv, based on an
initial chloride content of 1.0 mmol/g). A substitu-
tion of 0.72 mmol/g was determined by weight gain.
Synthesis was performed using the Boc-SPPS strat-
egy according to the following protocol: (i) CH2Cl2,
3×1 min; (ii) 47.5% TFA/47.5% CH2Cl2/2.5%
anisole/2.5% CH3SCH2CH3, 2 + 25 min; (iii)
CH2Cl2, 4×1 min; (iv) 10% DIEA/CH2Cl2, 2 +
1 min; (v) CH2Cl2, 3×1 min; (vi) DMF, 3×1 min;
(vii) Boc-amino acid (3 equiv)/BOP (3 equiv)/HOBt
(3 equiv)/NMM (6 equiv), 60 min; (viii) Kaiser test;
(ix) DMF, 3×1 min; (x) EtOH, 2×1 min.
After acidic deprotection of the Boc-protecting
group and neutralization of the resulting protonated
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amine, the resin was swelled in DMF and divided
into four equal portions using the ‘portioning-mixing’
method [17]. To each portion was coupled one of the
following four Boc-protected amino acids (Xxx): Boc-
Ala-OH, Boc-Lys(2-ClZ)-OH, Boc-Arg(Tos)-OH, and
Boc-Glu(OBzl)-OH, respectively. After the com-
pletion of coupling, as judged by the ninhydrin
test, the four portions were combined and washed
with DMF, methanol, and CH2Cl2. Boc-Phe-OH
and Boc-Tyr(Bzl)ψ[CH2S]Gly-OH were then succes-
sively coupled to the resin using the protocol described
above. Following drying, the cream-colored peptide
resin was weighed and yielded 258 mg of the desired
peptide resin product, Boc-Tyr(Bzl)ψ[CH2S]Gly-
Phe-Xxx-Leu-Merrifield resin.
Next, 258 mg peptide resin was treated with 5 mL
of 90% anhydrous HF/5% anisole/5% CH3CH2SCH3
in a Kel-F HF apparatus (Peptide Institute, Osaka,
Japan) at 0◦C for 60 min. The HF was evaporated
and the resin residue was washed with ethyl ether three
times, followed by extraction with 50% aqueous acetic
acid. After lyophilization, 97 mg of crude product was
obtained. AAA: Glu, 0.22 (0.25); Arg, 0.18 (0.25);
Ala, 0.22 (0.25); Lys, 0.20 (0.25); Leu, 1.00 (1.00);
Phe, 1.00 (1.00); H-Tyrψ[CH2S]Gly-OH, nd (1.00).
RP-HPLC characterization of the crude product re-
vealed two sets of peaks. The first set of peaks consists
of three major peaks at RT = 14.21 min, 14.65 min,
and 16.91 min. These were shown by their relative re-
tention times and their molecular weights (MS) to be
the desired pseudopeptides, H-Tyrψ[CH2S]Gly-Phe-
Xxx-Leu-OH, where Xxx = Arg, Lys, and Ala, Glu
(co-eluting), respectively. ES-MS: [M+H]+: Xxx =
Lys, 630.8 (found: 630.9); Xxx = Ala, 573.7 (found:
573.3); [M-H]−; Xxx =Arg, 656.8 (found: 656.7);
Xxx = Glu, 629.7 (found: 629.0). Similarly, a minor
second set of products consisted of three major peaks
at RT = 21.78, 22.13, and 24.67 min. These later elut-
ing, hydrophobic peaks, were identified by ES-MS as
the tyrosyl side chain modified benzyl-substituted side
products with an increased mass of 90 daltons in each
case, relative to the major product components. ES-
MS: [M+H]+: Xxx = Lys, 720.8 (found: 721.0); Xxx =
Ala, 663.7 (found: 663.4); [M-H]−; Xxx = Arg, 746.8
(found: 746.8); Xxx = Glu, 719.7 (found: 719.2).
Nα-(t-butyloxycarbonyl)-γ -(benzylester)-L-glutamic
acid-β-fluorenylmethyl ester (8)
To a solution of 3.37 g Boc-Glu(OBzl)-OH (10 mmol)
and 2.16 g HOFm (11 mmol) in EtOAc was added
0.81 mL pyridine (10 mmol) and 2.62 g Boc2O
(12 mmol). The reaction mixture was stirred at RT for
20 h. The EtOAc layer was washed with water, 1 N
HCl solution, water, 5% NaHCO3, saturated NaCl so-
lution, and dried with MgSO4. Evaporation of EtOAc
under reduced pressure afforded an oily residue. The
residue was dissolved in MeOH, stored at –15◦C, and
yielded 3.5 g (67.9%) white pure product. mp 93–
95 ◦C; 1H–NMR (500 MHz, CDCl3) δ 1.41 (s, 9H,
Boc); 1.84 (m, 1H,β-H); 2.10 (m, 1H,β-H); 2.31,
2.35 (m, 2H,γ -CH2); 4.19 (t, 1H, CH of Fm); 4.36
(m, 1H, α-H); 4.44–4.48 (m, 2H, CH2 of Fm); 5.05
(d, 1H, CONH); 5.10 (s, 2H, CH2 of Bzl); 7.24–7.73
(m, 13H, aromatic H of Fm and Bzl).
Nα-(t-butyloxycarbonyl)-L-glutamic acid-
α-fluorenylmethyl ester (9)
A spatula of Pd/C was added to a solution of 5 g (8) in
160 mL MeOH and 27 mL HOAc. The solution was
flushed with nitrogen and hydrogen successively, and
stirred at RT for 5 h. The reaction mixture was filtered
and washed on a fritted funnel. The filtrates were com-
bined and evaporated to an oily residue. The residue
was extracted with EtOAc. The combined organic ex-
tracts were washed with saturated NaCl solution, and
dried with MgSO4. Evaporation of EtOAc afforded
2.18 g crude product. The crude product was further
purified using flash chromatography to afford 1.48 g
(51.4%) pure white solid. mp: 67–70◦C; Rf (C) =
0.38; 1H–NMR (500 MHz, CDCl3) δ 1.42 (s, 9H,
Boc); 1.81 (m, 1H,β-H); 2.08 (m, 1H,β-H); 2.35 (m,
2H, γ -CH2); 4.20 (t, 1H, CH of Fm); 4.38 (m, 1H,
α-H); 4.46–4.52 (m, 2H, CH2 of Fm); 5.08 (d, 1H,
CONH); 7.28–7.75 (m, 8H, aromatic H of Fm).
Anchoring of (9) to hydroxymethyl resin (10)
To a solution of 1.28 g (9) (3.0 mmol) and 418.5 mg
HOBt (3.1 mmol) in THF was added 640.8 mg DCC
(3.1 mmol) in THF. The solution was stirred at RT for
15 min, followed by the addition of 2 g hydroxymethyl
resin (0.75 mmol/g) and 66.2 mg DMAP to the so-
lution. The reaction proceeded at RT for 12 h. The
resin was filtered, washed with THF, EtOH, CH2Cl2,
and driedin vacuo. The loading level of resin (10)
was determined as follows: 6.6 mg resin sample was
treated with 3 mL 20% piperidine/DMF solution for
20 min. After allowing the resin to settle, 0.4 mL of the
supernatant was withdrawn and diluted to 4 mL with
MeOH and UV absorbance determined to be 0.560
when recorded at 301 nm. The substitution level was
modi87.tex; 26/10/1998; 15:23; p.7
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determined to be 0.35 mmol/g, based on a value of




DCC (6.2 g, 30.0 mmol) was added portionwise to a
stirred solution of Nα-(t-butyloxycarbonyl)-L-aspartic
acid (7.0 g, 30.0 mmol) in 50 mL ethyl acetate at
0 ◦C. The reaction was kept at 0◦C for 1 h and
1 h at room temperature. The solution was filtered
and the solvent evaporated to dryness to obtain Nα-
(t-butyloxycarbonyl)-L-aspartic anhydride. The latter
was dissolved in 50 mL of dry THF with 6.2 g
(30.0 mmol) of 9-fluorenylmethanol. Next, 5.2 mL
(30 mmol) of DIEA were added and the solution
was stirred overnight. The solvent was evaporated
and the remaining solid partitioned between AcOEt
and a 5% citric acid solution. The aqueous solution
was acidified to pH 2 with 4 N HCl. The organic
phase was washed with a 5% citric acid solution,
then water, dried (MgSO4), and concentrated until
the appearance of the first crystals. The product (11)
was crystallized from ethyl acetate/hexane, filtered,
washed with hexane, and driedin vacuo. Yield 7.3 g
(63%). TLC Rf (C); 0.63; mp 156◦C; 1H NMR
(300 MHz, CDCl3) δ 1.50 (s, 9H, Me3C), 2.95 (ddd,
2H, CH2COOH), 4.24 (t, 1H, COOCH2CH), 4.50
(multiplet, 2H, COOCH2CH), 4.68 (t, 1H, NHCH),
5.55 (d, 1H, NH), 7.30–7.79 (cluster, 8H, aromatic H
of Fm).
Anchorage of (11) to hydroxymethyl resin (12)
The protocol for attachment of (11) to hydroxymethyl
resin is identical to the synthesis of the resin (10).
Substitution yield 0.53 mmol/g.
Anchorage of (11) to para-methylbenzhydrylamine
resin (13)
p-Methylbenzhydrylamine-resin hydrochloride (3.1 g,
0.7 meq/g) was placed in a reaction vessel and suc-
cessively washed with DCM (2×2 min×10 mL),
DIEA-DCM (1:9) (2×2 min×10 mL), DCM (2×2
min×10 mL), and DMF (2×2 min×10 mL). A
solution of (11) (1.8 g, 4.4 mmol), BOP (2.0 g,
4.5 mmol), HOBt (0.6 g, 4.4 mmol), and DIEA
(0.8 mL, 4.6 mmol) in DMF was added, and the re-
actor shaken for 2 h. The resin was washed again with
DMF (2×2 min×10 mL) and capped with a solution
composed of acetic anhydride (1.9 mL, 20.4 mmol),
pyridine (1.6 mL, 20.4 mmol) in DCM for 2 h. The
resin was washed again with DMF, DCM, and driedin
vacuo. Yield 3.75 g. Substitution yield 0.47 mmol/g.
General procedure for the synthesis of libraries
L1–L4
The cyclic pseudohexapeptide libraries were synthe-
sized analogously to the synthesis of L7. However
Boc-Proψ[CH2S]Gly-OH (6) was utilized instead of
Boc-Tyr(Bzl)ψ[CH2S]Gly-OH (5).
General procedure for the synthesis of libraries
L5–L34
L5–L19 were synthesized on 100 mg of resin (12)
(0.062 mmol of aspartic acid) in each reactor. L20–
L34 were synthesized in an identical fashion us-
ing100 mg (0.070 mmol of asparagine) of resin (13).
Peptide chain elongation
The resin was washed with DCM (3× 2 min
× 1 mL/syringe) and shaken with 50% TFA in
DCM (5 min × 1 mL/syringe). The TFA treat-
ment was repeated for 25 min more, the resin
washed as before, neutralized with DIEA-DCM
(1:9) (2 min × 1 mL/syringe), and washed again
with DCM. For each coupling, the protected amino
acids were individually weighed, combined, and
divided into individual syringes according to the
amino acid ratios shown in Table 3. For each
syringe, the proportionate values were Boc-L-Leu
(9.9 mg, 0.039 mmol), Boc-L-Lys(2-Cl-Z) (26.3 mg,
0.063 mmol), Boc-L-Ser(Bzl) (12.5 mg, 0.042 mmol),
Boc-L-Glu(OBzl) (14.2 mg, 0.042 mmol), Boc-L-
Arg(Tos) (27.1 mg, 0.063 mmol), Boc-L-Tyr(2,6-
Cl-Bzl) (21.8 mg, 0.050 mmol). Coupling reagent
amounts used were BOP (132.7 mg, 0.30 mmol),
HOBt (40.5 mg, 0.30 mmol), dissolved with the amino
acids, and DIEA in 1 mL of DMF per syringe. Each
mL of amino acid solution also contained 104µL
of DIEA (0.596 mmol). The mixture was stirred for
1 min prior to transferral to individual syringes. The
coupling of the single protectedδ-amino acid (pseudo-
dipeptide) was achieved with a four-fold excess of
Boc-Proψ[CH2S]Gly (82.4 mg, 0.30 mmol), BOP
(132.7 mg, 0.30 mmol), HOBt (40.5 mg, 0.30 mmol),
and DIEA 104µL (0.596 mmol) in 1 mL of DMF. The
block was shaken for 1 h and the completion of the
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couplings was monitored by testing of four randomly
chosen syringes using the Kaiser ninhydrin test.
Cyclization
The resin in each syringe was washed with DCM,
shaken for 20 min with 1 mL 20% piperidine in DMF,
filtered, and washed again with DCM. The Boc group
was cleaved with TFA and the resin neutralized as de-
scribed above. Next the condensing agents were pre-
activated as follows: HATU (3.42 g, 9.0 mmol), HOBt
(1.22 g, 9.0 mmol), and DIEA (3.12 mL, 17.9 mmol)
in 30 mL of DMF. The mixture was stirred for 1 min,
distributed to the 30 syringes, and the synthesis block
shaken for 2 h. The resin was washed with DCM and
driedin vacuoovernight.
Cleavage and purification
The cleavages were achieved in a 24-chamber multi-
ple HF apparatus. L5–L19 and L20–L34 were cleaved
separately. For each syringe, the resin was placed in
a cleavage vessel with 200µL of anisole and 5 mL
of anhydrous HF. The mixture was stirred at 0◦C for
1 h before removal of HF. For each reaction vessel,
the resin was transferred to a fritted glass funnel, and
the peptide products extracted with 50 mL of 30%
acetic acid each. The acetic acid solution was washed
twice with 25 mL diethyl ether and lyophilized to ob-
tain salty flakes. The peptide libraries were obtained
after solid phase extraction on reversed-phase Varian
Bond Elut C18: the remaining salts were washed out
with water and the peptides were extracted with 50 mL
of acetonitrile-water (1:1) and lyophilized. The amino
acid compositions of mixtures L8, L11, L14, L21, L24
and L30 were checked by amino acid analysis; results
are reproduced in Table 2.
Synthesis of L35
To a solution of 2.9 mg of L4 in 300µL of acetic
acid, 10µL of 30% hydrogen peroxide was added and
the mixture stirred for 1 h. The solution was diluted
in 2 mL of water and lyophilized to afford 2.8 mg of
product. The isomers were not separated. The mixture
was subjected to mass spectral analysis to establish the
presence of a new set of compounds, virtually identical
in profile, but with an increased mass of 16 Da.
Results and Discussion
Rationale for selection of targets
As one of several commonly used amide bond sur-
rogates, theψ[CH2S] surrogate is characterized by
its flexibility, enzyme resistance, and lipophilicity.
Its introduction within a peptide sequence can be
achieved using either a resin-bound nucleophilic dis-
placement approach [18] or a segment condensation
approach in which a pseudodipeptide is prepared in
solution before it is condensed onto the growing pep-
tide chain on the resin [19]. The resin bound approach
provides a fast and convenient method forψ[CH2S]
formation, but our previous studies on the synthesis
of a thioether macrocycle indicated that a consider-
ably more heterogeneous product was obtained from
the resin bound approach than that obtained using
a segment condensation strategy [18]. Most of the
side products generated in the resin bound approach
were presumably truncated peptide sequences, due to
the difficulty of achieving nearly 100% coupling ef-
ficiency between the thiol component and the resin
bound bromo-substituted peptide. In contrast, a pre-
formed ψ[CH2S]-containing pseudodipeptide could
be synthesized in solution and easily coupled to the
peptide resin with nearly quantitative yield (>99%),
thus improving the purity of the resulting pseudopep-
tide. Consequently, the segment condensation strategy
was used exclusively in the synthesis of ourψ[CH2S]-
containing mixtures. Figure 1 illustrates the general
procedures employed for the synthesis of preformed
pseudodipeptides, Boc-AAψ[CH2S]Gly-OH, where
AA = Pro or Tyr(Bzl).
Our work began with the careful examination of
small libraries containing four linearpseudopentapep-
tides (this nomenclature emphasizes that the surro-
gates are dipeptide mimics, even though the actual
synthesis is made up of only four ‘amino acid’ build-
ing blocks.) Further development led to the elabo-
ration of cyclic pseudohexapeptide libraries L1–L4,
and eventually to the synthesis of cyclic pseudohe-
xa-, hepta-, and octapeptide libraries L5–L34 (Ta-
ble 1). Cyclic peptides were chosen as targets for two
main reasons, the first being resistance to exopepti-
dases, and the second being that cyclization can reduce
the conformational flexibility of linear peptides, thus
making the peptide more stable. Often this can lead
to more selective binding to receptors. Similar ap-
proaches have led to the discovery of significant leads
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Table 1. Structure of pseudopeptide libraries L1–L35
Code # cpds Structure
L1 343 cyclo(Yyy-Yyy-Yyy-Proψ [CH2S]Gly-Glu)
L2 343 cyclo(Yyy-Yyy-Proψ [CH2S]Gly-Yyy-Glu)
L3 343 cyclo(Yyy-Proψ [CH2S]Gly-Yyy-Yyy-Glu)
L4 343 cyclo(Proψ [CH2S]Gly-Yyy-Yyy-Yyy-Glu)
L35 686 cyclo(Proψ [CH2SO]Gly-Yyy-Yyy-Yyy-Glu)
Code for Asx =
Asp Asn # cpds Structure
L5 L20 216 cyclo(Xxx-Xxx-Xxx-Proψ [CH2S]Gly-Asx)
L6 L21 216 cyclo(Xxx-Xxx-Proψ [CH2S]Gly-Xxx-Asx)
L7 L22 216 cyclo(Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Asx)
L8 L23 216 cyclo(Proψ [CH2S]Gly-Xxx-Xxx-Xxx-Asx)
L9 L24 1296 cyclo(Xxx-Xxx-Xxx-Xxx-Proψ [CH2S]Gly-Asx)
L10 L25 1296 cyclo(Xxx-Xxx-Xxx-Proψ [CH2S]Gly-Xxx-Asx)
L11 L26 1296 cyclo(Xxx-Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Asx)
L12 L27 1296 cyclo(Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Xxx-Asx)
L13 L28 1296 cyclo(Proψ [CH2S]Gly-Xxx-Xxx-Xxx-Xxx-Asx)
L14 L29 7776 cyclo(Xxx-Xxx-Xxx-Xxx-Xxx-Proψ [CH2S]Gly-Asx)
L15 L30 7776 cyclo(Xxx-Xxx-Xxx-Xxx-Proψ [CH2S]Gly-Xxx-Asx)
L16 L31 7776 cyclo(Xxx-Xxx-Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Asx)
L17 L32 7776 cyclo(Xxx-Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Xxx-Asx)
L18 L33 7776 cyclo(Xxx-Proψ [CH2S]Gly-Xxx-Xxx-Xxx-Xxx-Asx)
L19 L34 7776 cyclo(Proψ [CH2S]Gly-Xxx-Xxx-Xxx-Xxx-Xxx-Asx)
Xxx is a nearly equimolar mixture of lysine, leucine, arginine, glutamic acid, serine,
and tyrosine.
Yyy contains the same amino acids as Xxx plus alanine (seven total or 343 (73 per
mixture).
for either disulfide [20] or amide-based [21,22] cyclic
peptide analogs.
Each library was differentiated by the ring size,
the type of derivatized resin used, and the position of
the pseudodipeptide in the peptide sequence. Three
types of resin were utilized with side chain attach-
ment of glutamic acid L1–L4, aspartic acid L5–L19
and asparagine L20–L34. On-resin cyclization was
achieved after completion of each linear sequence.
The ring size was kept small (below 8 residues) to
prevent the involvement of the linear peptide in un-
productive secondary structure, and to afford efficient
cyclization. We refer to our approach consisting in
the migration of a pseudodipeptide unit along the pep-
tide chain as the ‘psi-scan’ method. By testing various
pseudopeptide groupings for their requisite activities,
this permits the determination of the best position in
the ring for the peptide bond surrogate as well as
effecting the separation of a large library into well de-
fined structural groups. In the synthesis of L5–L34, a
mixture of 6 amino acids was used in the couplings
with protecting groups as follows: Boc-Tyr(2,6-di-
Cl-Bzl), Boc-Arg(Tos), Boc-Leu, Boc-Lys(2-Cl-Z),
Boc-Glu(OChx), and Boc-Ser(Bzl). These six residues
were chosen to reflect the structural diversity of the
20 naturally occurring amino acids based on standard
Hansch criteria (steric, electronic, and hydrophobic
factors) [23]. Boc-Ala was added to the 6 previously
cited amino acids in the elaboration of L1–L4. We also
wished to keep the number of analogs per vial in a
moderate range as a compromise between single com-
pound assays [24] and the diversity possible in much
larger (20n or 60n) amino acid libraries [25].
Synthesis of linear peptides containing theψ[CH2S]
surrogate: Tyr(Bzl)ψ[CH2S]Gly
In order to identify any possible side products gener-
ated during the synthesis and to have better control
over the quality of theψ[CH2S]-containing cyclic
pseudopeptide libraries, we adopted a systematic ap-
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proach for the construction of pseudopeptide libraries.
Initially, a small linear pseudopeptide mixture, H-
Tyrψ[CH2S]Gly-Phe-Xxx-Leu-OH, where the Xxx
position was varied as lysine, alanine, arginine, and
glutamic acid, was synthesized to serve as the test
case for validation purposes. The synthesis began with
standard Boc-Leu-Merrifield resin. After acidic de-
protection of the Boc-protecting group, the resin was
divided into four equal portions, and each portion was
coupled to one of four amino acids (Lys, Arg, Ala, and
Glu), individually. The four resin portions were then
combined according to Furka’s ‘split and join’ tech-
nique, respectively [17], and the desired pseudopep-
tide mixture was assembled by successively coupling
Boc-D-Phe-OH and a preformed pseudodipeptide,
Boc-Tyrψ[CH2S]Gly-OH, to the resin. The result-
ing linear pseudopeptide mixture was finally released
from the resin using anhydrous HF [26] and the
mixture components characterized by RP-HPLC (un-
corrected for extinction coefficient variations). The
first three (major) peaks appeared at retention times
of 14.21, 14.65, and 16.91 (two components), re-
spectively and their masses, [M-H]−, 656.7, 629.0,
and [M+H]+ 573.3, 630.8 correspond to the theo-
retical values for linear pseudopeptides consisting of
Arg, Glu, Ala, and Lys in the general structure,
Tyrψ[CH2S]Gly-Phe-Xxx-Leu. Amino acid analysis
was consistent with the above assignments.
As seen in Figure 2a, a nearly identical pattern
of later eluting peaks appeared at 21.78, 22.13, and
24.67 min and each of these peaks showed molecular
masses of 90 units higher than their major counter-
parts, consistent with their being benzyl-substituted
analogs. The proton NMR pattern of the mixture (data
not shown) was also consistent with a modified tyro-
sine residue, as expected for an alkylation product.
Since the UV absorbance was carried out at 214 nm
(uncorrected for extinction coefficient variations), the
semi-quantitative estimation of 30% as representing
their bulk presence appears reasonably valid.
This type of side reaction was first systematically
studied by Erickson and Merrifield [27], and is typ-
ically overcome by the use of more hindered, albeit
more expensive, side chain protecting groups. Interest-
ingly, this side reaction was also observed in our early
studies on the synthesis ofψ[CH2NH]-containing
pseudopeptide mixtures, but only to a degree of about
10% [13]. Careful comparison of the RP-HPLC pro-
files between theψ[CH2S]-containing mixture and
the ψ[CH2NH]-containing mixture (Figure 2b) sug-
gested that theψ[CH2S] surrogate may play a role
in the modification of the tyrosine side chain dur-
ing the strong acid HF cleavage, even though the
ψ[CH2S]-containing pseudopeptides were different
from those of theψ[CH2NH]-containing pseudopep-
tide sequences. A possible explanation is that the
ψ[CH2S] surrogate might be attacked by the benzyl
cation to form an S-benzyl sulfonium intermediate
during the acidic cleavage. If such an intermedi-
ate were operative, it is evident that the thioalky-
lation is not permanent, as evidenced by the gen-
eration ofψ[CH2SO]-containing tyrosine side chain
modified pseudopeptides upon the oxidation of crude
pseudopeptide mixtures with hydrogen peroxide. This
is in contrast to what has been observed by Ramali-
gan et al. [28] for the S-alkylation of methionine side
chains by benzyl cation (S-alkylation) during the syn-
thesis of phosphotyrosine-containing peptides using
Boc-Tyr[PO3(Bzl)2].
This initial result convinced us thatψ[CH2S]-
containing pseudopeptide mixtures could be read-
ily accessed using a combination of solution phase
and solid phase synthesis methods. In addition, it
is likely that the quality of the pseudopeptide mix-
ture could be improved by the careful selection of
side chain protecting groups for tyrosine residues dur-
ing the synthesis. For example, a sterically hindered
2,6-dichlorobenzyl protecting group for the tyrosine
side chain hydroxyl group should minimize any ten-
dency for side chain modification significantly [27].
Based on these promising initial results, we under-
took the more ambitious task of synthesizing and
characterizing a series ofψ[CH2S]-containing cyclic
pseudopeptide libraries of different ring sizes.
Synthesis of cyclic pseudohexapeptide libraries
containing Proψ[CH2S]Gly L1–L4, using glutamic
acid for side chain attachment
The synthesis ofψ[CH2S]-containing cyclic pseudo-
peptide mixtures featured a resin bound cyclization
strategy. In this strategy, Boc-Glu-OFm was attached
by its side chain to hydroxymethyl resin. The Boc-
Glu-OFm derivative was prepared via two steps: syn-
thesis of Boc-Glu(OBzl)-OFm and hydrogenation of
Boc-Glu(OBzl)-OFm. The synthetic yield was 35%.
The major problem with this synthetic approach is the
partial premature loss of the OFm ester during hydro-
genation as previously reported [29], which reduces
overall yields.
In addition to the use of Boc-Glu-OFm during the
synthesis, the ‘multiple coupling’ method instead of
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‘portioning-mixing’ was used for the incorporation of
individual amino acids at the variable positions within
the peptide sequence. Although the portioning-mixing
method affords a nearly equimolar formation of each
pseudopeptide component in the mixture, it remains
a labor intensive process. On the other hand, the
multiple coupling method dramatically simplifies the
whole synthetic process, making the mixture synthesis
a one-pot (vessel) synthesis. During the synthesis, the
appropriate relative concentrations of each amino acid
(Leu, Arg, Tyr, Ser, Lys, Ala, and Glu) in the mixture
were modulated according to Geysen et al. [30] to en-
sure an approximately equal coupling proportion for
each amino acid.
The quality of the library was evaluated prior to
cleavage by amino acid analysis of the on-resin pep-
tide products (Table 2). The AAA results appear to be
in good agreement with the theoretical values for each
amino acid of the mixture, although the values for glu-
tamic acid and serine are higher than expected. While
the library composition appeared acceptable using
this criteria, additional characterization was achieved
using electrospray mass spectrometry.
A cyclic peptide library in which p positions are
coupled with a mixture of n amino acids contains
n∧p different compounds among which only (n+p–
1)!/p!(n–1)! masses are unique because of redundancy.
Indeed when one or more positions are fixed, the
number of compounds are a simple multiple of the
variable positions, as with linear peptide libraries.
Nevertheless, many different sequences possess com-
mon molecular weights. For example, our pseudo-
hexapeptide libraries contained 343 compounds with
only 84 different molecular weights; thus, for pur-
poses of partial characterization of mixtures, mass
spectroscopy is complementary to amino acid analy-
sis. Since many cyclic pseudopeptides in the mixture
differ only slightly in their molecular masses (one to
several mass units), we would expect a fairly sym-
metric distribution of molecular weights for mixture
L4. Further expansion of the molecular weight region
(molecular weight envelope) led to the unambiguous
assignment of molecular weights for many expected
cyclic pseudohexapeptides (Figure 3). Because some
of the components of the library contained only a pos-
itively charged residue (Arg, Lys) while others only a
negatively charged residue (Asp, Glu), it was neces-
sary to run all samples in both negative and positive
modes to visualize the maximum number of com-
ponents. Again, due to the small molecular weight
differences between pseudopeptides, the molecular
weight peaks in the mass spectrum were broad, and
not all molecular masses were clearly revealed in the
spectrum. Electrospray mass spectrometry is not as
sensitive for compounds without acidic or basic sites,
as it is for compounds with easily charged sites. Nev-
ertheless, the overall results from ES-MS strongly
suggested that most of the desired products, if not all
of them, were present in the mixture. Moreover, very
few side product peaks were observed in the spectrum,
suggesting the success of the whole synthesis. This
conclusion was further supported by the amino acid
analysis results of mixture L4, which gave acceptable
ratios for each of the amino acids in the mixture. The
overall amino acid analysis results also support the
approximate equal incorporation of each amino acid
at the variable positions within the peptide sequence
using the multiple coupling method [30].
The ψ[CH2SO] (R and S)-containing linear and
cyclic pseudohexapeptide mixtures were easily gener-
ated by oxidizingψ[CH2S]-containing mixtures using
aqueous acidic hydrogen peroxide. In a validation
study, a linear mixture of 4 pseudopeptides was ox-
idized by H2O2 in acetic acid at room temperature.
The oxidation was monitored by HPLC, and found
to be complete in less than 60 min. The identi-
ties of the resultingψ[CH2SO] (R and S)-containing
pseudopeptides were confirmed by ES-MS. Based on
this initial study, the 343-component mixture L4 was
subsequently oxidized to generate the corresponding
ψ[CH2SO] (R and S)-containing mixture L35.
The latter was thoroughly characterized by ES-
MS. A direct comparison of the mass spectra between
mixtures L4 (ψ[CH2S]) and L35 (ψ[CH2SO]) clearly
reveals a 16 mass unit difference between two mix-
tures (Figures 4a, b). This analysis also provides
confidence that there are no significant product com-
ponents lacking the thiomethylene ether surrogate in
the parent mixture.
In conclusion, reasonably cleanψ[CH2S] and
ψ[CH2SO] (R and S)-containing pseudopeptide mix-
tures can be prepared using a combination of solution
phase and solid phase synthesis techniques. Cyclic
mixtures were effectively synthesized using the Boc-
Glu-OFm resin-bound cyclization strategy and the
so-called ‘multiple coupling’ method.
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Table 2. Amino acid analysis L1, L2, L3, and L4. Samples were hydrolyzed at 110◦C for
24 h using 6 N HCl
L1 L2 L3 L4
calc. found calc. found calc. found calc. found
Glu 1.43 1.82 1.43 1.73 1.43 1.75 1.43 1.62
Leu 0.43 0.40 0.43 0.38 0.43 0.39 0.43 0.35
Lys 0.43 0.44 0.43 0.42 0.43 0.40 0.43 0.36
Arg 0.43 0.43 0.43 0.49 0.43 0.46 0.43 0.44
Ser 0.43 0.58 0.43 0.61 0.43 0.56 0.43 0.53
Ala 0.43 0.43 0.43 0.43 0.43 0.42 0.43 0.44
Tyr 0.43 0.41 0.43 0.40 0.43 0.43 0.43 0.43
Synthesis of cyclic pseudohexa-, hepta-, and
octapeptide libraries containing Proψ[CH2S]Gly
L5–L34 with Asp and Asn side chain attachment
The resin preparation consisted in the side chain at-
tachment of Boc-L-Asp-OFm to the solid support,
a method developed by Rovero and colleagues [9].
Two types of resin were synthesized by attaching
Boc-L-Asp-OFm [31] to either apara-hydroxymethyl
polystyrene solid support leading to aspartic acid
resin or to apara-methylbenzhydrylaminepolystyrene
resin to obtain an asparagine resin. The substitution
yields were evaluated by UV quantification of fluo-
renylmethanol on a known amount of resin [32] and
found to be 0.53 mmol/g for asparagine resin (12) and
0.47 mmol/g for asparagine resin (13). Two libraries
were generated in parallel fashion using these two
resins: L5–L19 (Table 1) represent the aspartic acid
based libraries and L20–L34 (Table 1) reflect their
asparagine counterparts.
The synthesis of the libraries was performed in
a synthesis block consisting of 42 polypropylene sy-
ringes equipped with a plastic frit [33]. Each of the
syringes was loaded with 100 mg of amino acid
substituted resin and acted as an individual reac-
tion vessel. Boc chemistry was used to elongate the
peptide and included 50% trifluoroacetic acid cleav-
age and a phosphonium-based condensing agent [34]
BOP/HOBt. The resin was kept in suspension through
agitation of the synthesis block with a rotary shaker.
Completion of the couplings was monitored by the
Kaiser ninhydrin test [35] on 4 syringes chosen at ran-
dom at each step. In the event of a positive (blue) color,
the couplings for all vials were repeated.
A mixture of the 6 previously cited amino acids
(Leu, Arg, Tyr, Ser, Lys, and Glu) was used in each of
the variable position couplings. As described earlier,
attachments were achieved using a four-fold excess
of amino acids in ratios determined by Geysen [30]
in such a way that nearly equivalent amounts of each
single amino acid are produced in the products after
coupling.
After completion of the synthesis of the linear
peptides, the N-terminal Boc protecting group was
cleaved using trifluoroacetic acid, and the C-terminal
fluorenylmethyl ester protecting function was re-
moved with 20% piperidine in DMF. On-resin cycliza-
tions were carried out using HATU/HOBt [36] for 2 h.
A much faster cyclization kinetic was afforded when
using the uronium-based coupling reagent HATU in-
stead of BOP. Cleavage and side chain deprotection
were achieved with a 24-chamber HF apparatus [37]
using anisole as a scavenger. After removal of HF, the
resin was transferred to a fritted funnel, triturated with
diethyl ether for removal of remaining scavengers,
and the peptide-product extracted with a 30% acetic
acid solution. Salt-free peptides were afforded after
reversed solid phase extraction using Varian Bond Elut
C18. The products were individually lyophilized and
obtained with an average percent yield of 50%.
The mixtures were characterized by amino acid
analysis (Table 3). Even though serine and tyrosine
were damaged in the hydrolysis process, the exper-
imental results were consistent with the theoretical
values for the other amino acids (deviations remained
below 10%, as commonly observed). Further analysis
was carried out using ES-MS (Figures 5a, b) and the
spectra appeared to contain all of the expected com-
pounds, with allowances for ion-suppression effects
and peak overlap.
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Table 3. Amino acid analysis of randomly selected libraries: L8, L11, L14, L21, L24 and L30. Samples were hydrolyzed at 110◦C for 24 h
using 6 N HCl
L8 L11 L14 L21 L24 L30
calc. found calc. found calc. found calc. found calc. found calc. found
Asp/Asn 1 1.25 1 1.12 1 1.23 1 1.08 1 1.17 1 1.08
Leu 0.50 0.45 0.66 0.67 0.83 0.79 0.50 0.46 0.66 0.59 0.83 0.83
Lys 0.50 0.52 0.66 0.71 0.83 0.83 0.50 0.51 0.66 0.64 0.83 0.78
Glu 0.50 0.49 0.66 0.61 0.83 0.87 0.50 0.53 0.66 0.70 0.83 0.81
Arg 0.50 0.50 0.66 0.61 0.83 0.80 0.50 0.48 0.66 0.65 0.83 0.82
Ser 0.50 0.46 0.66 0.62 0.83 0.76 0.50 0.46 0.66 0.64 0.83 0.82
Tyr 0.50 0.44 0.66 0.61 0.83 0.81 0.50 0.46 0.66 0.62 0.83 0.79
Biological assays
Theψ[CH2S] pseudopeptide libraries L5–L34, which
incorporated the Proψ[CH2S]Gly ‘psi-scan’ motif,
were screened in more than 60 biological assays. All
mixtures were tested for theirin vitro anti-HIV activity
by the National Cancer Institute (NCI). The com-
pounds were tested using an 8-point assay with con-
centrations varying from 0.003µg/mL to 10µg/mL.
Activities were measured after a 6-day incubation pe-
riod at 37◦C. Thus far none of the tested libraries have
provided a positive hit in this system.
Conclusions
The approach undertaken for the synthesis of cyclic
pseudopeptides featuring side chain attachment of the
first amino acid to the resin, utilization of ratios of
amino acids for coupling of mixtures, on-resin cycliza-
tion, and utilization of a preformed pseudodipeptide
for the introduction of the peptide bond surrogate has
been validated by the MS studies, as well as by the
amino acid analysis data. Our results confirm that lin-
ear and undeprotected compounds, dimers, as well as
deletion peptides remain low. While MS can be a very
effective tool to study mixtures, it does show some
weaknesses due to the intrinsic nature of the products
being analyzed. These include:
– Redundant peptides are indistinguishable.
– The peak distribution does not reflect the isobaric
composition of the mixture, due to ion suppres-
sion effects. These effects are more pronounced
for electrospray mass spectrometry of small pep-
tides, where many contain neither basic nor acidic
residues. For larger peptides, electrospray can
show a variation in the number of charges, causing
a different type of complication.
– Low resolution mass spectrometry cannot readily
distinguish peptides of similar molecular weight.
Nevertheless, correlations between the scope and di-
versity of a library, as manifested by the lower and
upper molecular weight limits, the qualitative distrib-
ution of molecular weights (assisted by the ‘quantized’
nature of MW distribution), the absence of signifi-
cant lower molecular weight fractions, and the lack
of significant products in the dimer region, com-
bine to validate the quality of the synthesis. AAA
can also be a reliable correlate, especially when
proper ratios must correspond to a larger dynamic
range due to the appearance of fixed amino acids
such as Asp or Asn in our samples. Finally, the
oxidation ofψ[CH2S] to ψ[CH2SO], which gener-
ates ‘(pseudopeptide) libraries from (pseudopeptide)
libraries’ and corresponds to a net addition of 16 dal-
tons to each member of the precursor library, also adds
greatly to the confidence of the synthetic process. Be-
cause this modification does not dramatically change
the acidity or basicity of the peptide, the ESI spec-
trum should only shift in mass; the relative intensity
of the MS peaks would not be expected to change
as they might for a modification adding a charged
site: e.g., phosphorylation. Coupled with our previous
systematic studies for the racemization/epimerization
problem [10], we believe our current products have
been produced in their theoretical distributions with a
reasonably high level of confidence, especially consid-
ering the complex nature of pseudopeptide synthesis in
general and cyclic pseudopeptides in particular.
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